The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients*
Abstract
OBJECTIVE: The role of intensive insulin therapy in medical surgical intensive care patients remains unclear. The objective of this study was to examine the effect of intensive insulin therapy on mortality in medical surgical intensive care unit patients. DESIGN: Randomized controlled trial. SETTINGS: Tertiary care intensive care unit. PATIENTS: Medical surgical intensive care unit patients with admission blood glucose of > 6.1 mmol/L or 110 mg/dL. INTERVENTION: A total of 523 patients were randomly assigned to receive intensive insulin therapy (target blood glucose 4.4-6.1 mmol/L or 80-110 mg/dL) or conventional insulin therapy (target blood glucose 10-11.1 mmol/L or 180-200 mg/dL). MEASUREMENTS AND MAIN OUTCOMES: The primary end point was intensive care unit mortality. Secondary end points included hospital mortality, intensive care unit and hospital length of stay, mechanical ventilation duration, the need for renal replacement therapy and packed red blood cells transfusion, and the rates of intensive care unit acquired infections as well as the rate of hypoglycemia (defined as blood glucose < or = 2.2 mmol/L or 40 mg/dL). There was no significant difference in intensive care unit mortality between the intensive insulin therapy and conventional insulin therapy groups (13.5% vs. 17.1%, p = 0.30). After adjustment for baseline characteristics, intensive insulin therapy was not associated with mortality difference (adjusted hazard ratio 1.09, 95% confidence interval 0.70-1.72). Hypoglycemia occurred more frequently with intensive insulin therapy (28.6% vs. 3.1% of patients; p < 0.0001 or 6.8/100 treatment days vs. 0.4/100 treatment days; p < 0.0001). There was no difference between the intensive insulin therapy and conventional insulin therapy in any of the other secondary end points. CONCLUSIONS: Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia. Based on these results, we do not advocate universal application of intensive insulin therapy in intensive care unit patients. TRIAL REGISTRATION: Current Controlled Trials registry (ISRCTN07413772) http://www.controlled-trials.com/ISRCTN07413772/07413772; 2005.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overall rate of severe hypoglycemic events in international trials ranged between 5% to 28.6%.3,4,7,8,18,19”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [18]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664 · cited 2×
“nonoperative), history of diabetes, inclusion blood glucose, ICU admission diagnosis and the presence of chronic illnesses using APACHE II definitions (15), vasopressor therapy (defined as the use of any vasopressor infusion except dopamine 5 g/ kg/min), mechanical ventilation, serum creatinine, platelet count, biliru…”
MethodAPACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“At baseline the following data were recorded: patient’s demographics, weight, height, body mass index (BMI), Acute Physiology and Chronic Health Evaluation (APACHE) II score (15), Sequential Organ Failure Assessment (SOFA) score (16), admission category (postoperative vs.”
MethodPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Insulin therapy protects the central and peripheral nervous system of intensive care patients
Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., & Wouters, P. J. (2005) · Neurology · doi:10.1212/01.wnl.0000158442.08857.fc · Cited by 642 · cited 1×
“found that IIT reduced ventilation dependency, intracranial pressure, seizures, and diabetes insipidus, but did not affect mortality (27).”
Background
Research works printed but not linked: 2
- Orford, 2006, Crit Care Resusc, 8, 230
- Devos, 2007, Intensive care Med, 33, S189
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Peberdy, M. A., Callaway, C. W., Neumar, R. W., Geocadin, R. G., Zimmerman, J. L., Donnino, M., Gabrielli, A., Silvers, S. M., Zaritsky, A. L., Merchant, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971002 · Cited by 2,522
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
MethodResultHyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Falciglia, M., Freyberg, R. W., Almenoff, P. L., D’Alessio, D. A., & Render, M. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b083f7 · Cited by 576
“Nevertheless, consideration of the differential effects of hyperglycemia in patients with diabetes is important, particularly in interpreting systematic reviews of insulin treatment during critical illness that are unable to adequately examine effects separately in individuals with and without diabetes (57), as well a…”
BackgroundJacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
“54] Did not achieve target glucose, inadequate sample to detect mortality difference Arabi et al (19) Medical and surgical Randomized 80–110 mg/dL vs.”
BackgroundInfluentialThe Effect of Short-Term Hyperglycemia on the Innate Immune System
Jafar, N., Edriss, H., & Nugent, K. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.011 · Cited by 463
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Glucose variability is associated with intensive care unit mortality*
Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4be9 · Cited by 437
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
“One possible explanation for the divergent results among such trials may relate to the incidence of severe hypoglycemia sustained by patients in the interventional arms of randomized trials [6-11].”
ResultToward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Arabi, Y. M., Tamim, H. M., Dhar, G. S., Al-Dawood, A., Al-Sultan, M., Sakkijha, M. H., Kahoul, S. H., & Brits, R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005074 · Cited by 353
Self-citationJoannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
“There is some evidence for excess mortality or extended length of stay among patients in the MICU experiencing 1 or more episodes of severe hypoglycemia related to IIT (7, 8, 45, 46).”
BackgroundUmpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
“6% depending on the intensity of glycemic control (9,12,16,20,28,29).”
BackgroundTight Glycemic Control versus Standard Care after Pediatric Cardiac Surgery
Agus, M. S. D., Steil, G. M., Wypij, D., Costello, J. M., Laussen, P. C., Langer, M., Alexander, J. L., Scoppettuolo, L. A., Pigula, F. A., Charpie, J. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206044 · Cited by 274
Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review
Kansagara, D., Fu, R., Freeman, M., Wolf, F., & Helfand, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00008 · Cited by 255
“In 1 trial (35), the mortality risk in patients treated with IIT who had hypoglycemia was double that in control patients with hypoglycemia (25.”
BackgroundInfluentialIntensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?
Van den Berghe, G., Schetz, M., Vlasselaers, D., Hermans, G., Wilmer, A., Bouillon, R., & Mesotten, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0663 · Cited by 235
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2756 · Cited by 211
Kavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205
Tight Glycemic Control in Critically Ill Children
Agus, M. S. D., Wypij, D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V., Luckett, P. M., Alexander, J. L., Asaro, L. A., Curley, M. A. Q., Steil, G. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612348 · Cited by 204
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P., Oudemans-van Straaten, H. M., Ronco, C., Schetz, M. R. C., & Woittiez, A. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1678-y · Cited by 178
“general [189, 190] ICU patients and a meta-analysis [191]”
Yamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4523-0 · Cited by 171
Scientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control
Akhtar, S., Barash, P. G., & Inzucchi, S. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c6be63 · Cited by 176
Glucose control in the intensive care unit
Fahy, B. G., Sheehy, A. M., & Coursin, D. B. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a19ceb · Cited by 170
Honarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006174 · Cited by 201
Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis
Kramer, A. H., Roberts, D. J., & Zygun, D. A. (2012) · Critical Care · doi:10.1186/cc11812 · Cited by 170
Perioperative glycaemic control for diabetic patients undergoing surgery
Buchleitner, A. M., Martínez-Alonso, M., Hernández, M., Solà, I., & Mauricio, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub2 · Cited by 168
A.S.P.E.N. Clinical Guidelines: Nutrition Support of Adult Patients With Hyperglycemia
McMahon, M. M., Nystrom, E., Braunschweig, C., Miles, J., Compher, C., & the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112452001 · Cited by 164
“However, more recent large clinical trials failed to show benefit when such an aggressive target was achieved.(25,27-31,35) The largest randomized controlled trial that used primarily enteral nutrition at levels of energy intake that were appropriate actually found a higher mortality in patients treated with intensive…”
BackgroundThe NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3757-6 · Cited by 159
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial
Kalfon, P., Giraudeau, B., Ichaï, C., Guerrini, A., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3189-0 · Cited by 174
“gested that the difference in outcome between the two Leuven studies [4, 9] and subsequent RCTs [10–13] could be related to the excessive calories provided parenterally”
ResultBench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 169
Arabi, Y. M., Tamim, H., & Rishu, A. H. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a381ad · Cited by 143
Self-citationInternational recommendations for glucose control in adult non diabetic critically ill patients
Ichai, C., Preiser, J.-C., (SFAR), F. T. S. F. D.-R., & Société de Réanimation de langue Française (SRLF) and the Experts group (2010) · Critical Care · doi:10.1186/cc9258 · Cited by 127
“However, there is no study that can be used as a basis to recommend any given interval between measurements as a function of the equilibrium observed: from 30 minutes (in cases of hypoglycemia or severe hyperglycemia) to 4 hours depending upon glucose level stability and study [4,15-19].”
BackgroundResultInfluentialPeri-operative glycaemic control regimens for preventing surgical site infections in adults
Kao, L. S., Meeks, D. W., Moyer, V. A., & Lally, K. P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006806.pub2 · Cited by 126
Arabi, Y. M., Haddad, S. H., Tamim, H., Rishu, A. H., Sakkijha, M. H., Kahoul, S. H., & Britts, R. J. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109353439 · Cited by 121
Self-citationS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
Enhanced Recovery After Surgery: It's Time to Change Practice!
Steenhagen, E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615622640 · Cited by 141
Hyperglycemia in Critical Illness: A Review
Brealey, D. A., & Singer, M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300604 · Cited by 112
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
Acute insulin resistance following injury
Li, L., & Messina, J. L. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.06.004 · Cited by 110
“In addition, intensive insulin therapy increases the incidence of hypoglycemic episodes with the potential for negative outcomes [1,22,24,30-32] and in some cases, the complications due to hypoglycemia may negate the positive effects of tight glucose control.”
BackgroundTreating Hyperglycemia in Neurocritical Patients: Benefits and Perils
Godoy, D. A., Napoli, M. D., & Rabinstein, A. A. (2010) · Neurocritical Care · doi:10.1007/s12028-010-9404-8 · Cited by 113
“Yet, subsequent trials showed much less favorable results [111–114].”
ResultThe optimal target for acute glycemic control in critically ill patients: A network meta-analysis.
Yatabe, T., Inoue, S., Sakaguchi, M., & Egi, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4558-2 · Cited by 95
Nutrition update in gastric cancer surgery
Kubota, T., Shoda, K., Konishi, H., Okamoto, K. K., & Otsuji, E. (2020) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12351 · Cited by 100
Abdelmalak, B., Knittel, J. G., Abdelmalak, J. B., Dalton, J. E., Christiansen, E. H., Foss, J. F., ARGALIOUS, M. Y., Zimmerman, R. S., & den Berghe, G. V. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet297 · Cited by 99
Krinsley, J. S., Meyfroidt, G., den Berghe, G. V., Egi, M., & Bellomo, R. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834f0009 · Cited by 100
“0.72 (0.63–0.83) 0.85 (0.67–1.07) <0.0001 0.1698 Arabi et al. 2008 [5] 19/134 (14.2”
InfluentialThe metrics of glycaemic control in critical care
Mackenzie, I. M. J., Whitehouse, T., & Nightingale, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2103-2 · Cited by 97
“Other investigators have not been able to replicate these results [11, 12].”
ResultGlycaemic control targets after traumatic brain injury: a systematic review and meta-analysis
Hermanides, J., Plummer, M. P., Finnis, M., Deane, A. M., Coles, J., & Menon, D. K. (2018) · Critical Care · doi:10.1186/s13054-017-1883-y · Cited by 100
“In five of the included studies, it was clear after review of the full text that patients with TBI were included in the study population [7, 8, 14, 23, 24].”
BackgroundInfluentialLan, C., Tsai, H., Chen, Y., & Ko, W. (2010) · Artificial Organs · doi:10.1111/j.1525-1594.2009.00909.x · Cited by 94
Glycaemic control in the perioperative period
Sebranek, J. J., Lugli, A. K., & Coursin, D. B. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet381 · Cited by 100
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Newton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
“3,4,7,8,18,19 In this trial, the number of patients with severe hypoglycemia was 3.9% in the computer-based and 5.6% in the standard paper algorithm.”
InfluentialMosier, M. M., & Pham, T. N. (2009) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181bfb68f · Cited by 85
Metabolic and Nutrition Support in the Chronic Critical Illness Syndrome
Schulman, R. C., & Mechanick, J. I. (2012) · Respiratory Care · doi:10.4187/respcare.01620 · Cited by 97
Glucose Control in the ICU: A Continuing Story
Preiser, J., Chase, J. G., Hovorka, R., Joseph, J. I., Krinsley, J. S., Block, C. E. M. D., Desaive, T., Foubert, L. A., Kalfon, P., Pielmeier, U., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816648713 · Cited by 88
Damage control in trauma and abdominal sepsis
Waibel, B. H., & Rotondo, M. F. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181ec5cbe · Cited by 80
Dexamethasone, light anaesthesia, and tight glucose control (DeLiT) randomized controlled trial
Abdelmalak, B., Bonilla, A. M., Mascha, E. J., Maheshwari, A., Tang, W. H. W., You, J., Ramachandran, M. A., Kirkova, Y., Clair, D., Walsh, R. M., et al. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet050 · Cited by 82
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Damage Control for Intra-Abdominal Sepsis
Waibel, B. H., & Rotondo, M. F. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.01.006 · Cited by 77
Glucose Control and Mortality in Patients with Severe Traumatic Brain Injury
Griesdale, D. E. G., Tremblay, M.-H., McEwen, J., & Chittock, D. R. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9249-1 · Cited by 80
“Regardless of the setting, intensive insulin therapy has consistently been associated with an increased risk of severe hypoglycemia [8, 10–13, 16–19, 22–24].”
BackgroundBlood glucose dysregulation and cognitive outcome in ARDS survivors
Hopkins, R. O., Suchyta, M. R., Snow, G. L., Jephson, A. R., Weaver, L. K., & Orme, J. F. (2010) · Brain Injury · doi:10.3109/02699052.2010.506861 · Cited by 85
Qaseem, A., Chou, R., Humphrey, L. L., Shekelle, P., Shekelle, P., Chou, R., Dallas, P., Denberg, T. D., Fitterman, N., Forciea, M. A., et al. (2013) · American Journal of Medical Quality · doi:10.1177/1062860613489339 · Cited by 78
“Although the evidence is not clear regarding the consequences of hypoglycemia in hospitalized patients, some studies have shown that increased mortality is associated with IIT and hypoglycemia(20) or extended length of stay among patients experiencing 1 or more episodes of hypoglycemia.(21-24) Additional concerns abou…”
BackgroundSchlenk, F., Vajkoczy, P., & Sarrafzadeh, A. S. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9222-z · Cited by 74
“This is consistent to a recent randomized controlled trial, demonstrating that intensive insulin therapy had a higher incidence of hypoglycemia without showing any substantial benefit [ 36 ].”
ResultAssociation between statin therapy and outcomes in critically ill patients: a nested cohort study
Harbi, S. A. A., Tamim, H., & Arabi, Y. M. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-12 · Cited by 80
“1 mmol/L or 180–200 mg/dl) [25].”
Self-citationFarrokhi, F., Klindukhova, O., Chandra, P., Peng, L., Smiley, D. D., Newton, C. A., Pasquel, F. J., Fereira, M. E., & Umpierrez, G. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600505 · Cited by 79
“# patients < 70 mg/dl, % 89 (19) 61 (23) 28 (13) 0.”
Surgical Site Infection in Colorectal Surgery: A Review of the Nonpharmacologic Tools of Prevention
Murray, B. W., Huerta, S., Dineen, S. P., & Anthony, T. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.07.025 · Cited by 84
Glucose homeostasis, nutrition and infections during critical illness
Ingels, C., Vanhorebeek, I., & den Berghe, G. V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.12.033 · Cited by 78
Untangling glycaemia and mortality in critical care
Uyttendaele, V., Dickson, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2017) · Critical Care · doi:10.1186/s13054-017-1725-y · Cited by 75
Calorie delivery and clinical outcomes in the critically ill: a systematic review and meta-analysis
Parikh, H. G., Miller, A., Chapman, M., Moran, J. L., & Peake, S. L. (2016) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00927-4 · Cited by 69
Glycemic Control in the Intensive Care Unit and during the Postoperative Period
Lena, D., Kalfon, P., Preiser, J., Ichaï, C., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182078843 · Cited by 69
Shetty, S., Inzucchi, S. E., Goldberg, P. A., Cooper, D. A., Siegel, M. D., & Honiden, S. (2011) · Endocrine Practice · doi:10.4158/ep11260.or · Cited by 70
Gao, S., Yang, Z., Shi, R., Xu, D., Li, H., Xia, Z., Wu, Q., Yao, S., Wang, T., & Yuan, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.018 · Cited by 66
Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis
Yao, R.-Q., Ren, C., Wu, G., Zhu, Y., Xia, Z., & Yao, Y.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.43447 · Cited by 70
“Rates of infection were documented in 19 trials[13, 42, 43, 45-47, 50, 52, 55-57, 59, 63, 65, 66, 75, 88, 89, 92].”
BackgroundResultInfluentialDysglycemia and Glucose Control During Sepsis
Plummer, M. P., & Deane, A. M. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.010 · Cited by 68
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 68
Glucose control in critical care
Clain, J. M., Ramar, K., & Surani, S. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i9.1082 · Cited by 65
Inpatient Management of Diabetes and Hyperglycemia
Bogun, M. M., & Inzucchi, S. E. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.008 · Cited by 67
Blood Glucose Control in the Intensive Care Unit: Benefits and Risks
Gunst, J., & den Berghe, G. V. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00702.x · Cited by 65
Glucose management in critically ill adults and children
Mesotten, D., Preiser, J., & Kosiborod, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00223-5 · Cited by 63
Ling, Y., Li, X., & Gao, X. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.02.013 · Cited by 69
van Steen, S. C. J., Rijkenberg, S., Limpens, J., der Voort, P. V., Hermanides, J., & DeVries, J. H. (2017) · Sensors · doi:10.3390/s17010146 · Cited by 61
Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After Study*
Luethi, N., Cioccari, L., Biesenbach, P., Lucchetta, L., Kagaya, H., Morgan, R., Muzio, F. D., Presello, B., Gaafar, D., Hay, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003087 · Cited by 61
“In the Leuven trials ( 20% with diabetes), intensive insulin therapy (IIT) targeting normoglycemia resulted in significantly lower prevalence of acute kidney injury (AKI) (24, 25).”
BackgroundInfluentialHyperglycemia and Acute Kidney Injury During the Perioperative Period
Mendez, C. E., Mesropian, P. J. D., Mathew, R. O., & Slawski, B. A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0701-7 · Cited by 59
“Arabi et al. 2008 [71] Medical-surgical ICU patients; >16 % surgical patients 523 RCT: intensive insulin therapy (glucose target 80–110 mg/dL) or conventional insulin therapy (target 180–200 mg/dl) Need for RRT No difference in need for RRT (11.7 vs. 12.1”
BackgroundInfluentialGlycemic control in critically ill patients
Hsu, C.-W. (2012) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v1.i1.31 · Cited by 70
Schultz, M. J., Harmsen, R. E., & Spronk, P. E. (2010) · Critical Care · doi:10.1186/cc8966 · Cited by 53
“In addition, an increase was noticed in the number of patients who received insulin, or there was an increase in the amount of infused insulin in the control group [2-7].”
BackgroundMethodInfluentialFriedrich, J. O., Chant, C. A., & Adhikari, N. K. J. (2010) · Critical Care · doi:10.1186/cc9240 · Cited by 64
Ley, E. J., Srour, M. K., Clond, M. A., Barnajian, M., Tillou, A., Mirocha, J., & Salim, A. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182146d66 · Cited by 55
What Is a NICE-SUGAR for Patients in the Intensive Care Unit?
Bellomo, R., & Egi, M. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60557-0 · Cited by 51
Relative Hypoglycemia in Diabetic Patients With Critical Illness
Kwan, T. N., Hessels, L., Marhoon, N., Robbins, R., Mårtensson, J., Ekinci, E. I., & Bellomo, R. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004213 · Cited by 51
Continuous Insulin Infusion: When, Where, and How?
Kelly, J. L. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.218 · Cited by 60
Glycaemic Fluctuation Predicts Mortality in Critically Ill Patients
Al‐Dorzi, H. M., Tamim, H., & Arabi, Y. M. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800413 · Cited by 48
Self-citationDrincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Harbi, S. A. A., Tamim, H., Al‐Dorzi, H. M., Sadat, M., & Arabi, Y. M. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0047-z · Cited by 49
Self-citationGlucose and the Injured Brain-Monitored in the Neurointensive Care Unit
Rostami, E. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00091 · Cited by 50
Metadata
- Authors
- Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., Kahoul, S. H., Britts, R. J., & Sakkijha, M. H.
- Affiliations
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Venue
- Critical Care Medicine
- Published
- 2008-12
- Volume
- 36
- Issue
- 12
- Pages
- 3190-3197
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2058406121
- Cited by
- 471
- References
- 27
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 19 · 2019: 21 · 2018: 23 · 2017: 23 · 2016: 32 · 2015: 39 · 2014: 25 · 2013: 28 · 2012: 41
- FWCI
- 40.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, conventional insulin therapy, glycemic control, critically ill patients, ICU mortality, hypoglycemia, glycemic targets, mechanical ventilation, renal replacement therapy, intensive care unit infections, length of hospital stay, hyperglycemia, sepsis, trauma, neurocritical care
- MeSH terms
- Blood Glucose, Body Weights and Measures, Demography, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Length of Stay, Male, Middle Aged, Postoperative Period, Respiration, Artificial, Surgical Procedures, Operative, Critical Illness, Hospital Mortality, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.